Reaktionsgleichung
[Br:1][C:2]1[CH:10]=[CH:9][C:5]([C:6]([OH:8])=O)=[C:4]([S:11]([CH3:14])(=[O:13])=[O:12])[CH:3]=1.[CH3:15][C:16]1[CH:21]=[C:20]([CH3:22])[CH:19]=[CH:18][C:17]=1[N:23]1[CH2:28][CH2:27][NH:26][CH2:25][CH2:24]1>>[Br:1][C:2]1[CH:10]=[CH:9][C:5]([C:6]([N:26]2[CH2:27][CH2:28][N:23]([C:17]3[CH:18]=[CH:19][C:20]([CH3:22])=[CH:21][C:16]=3[CH3:15])[CH2:24][CH2:25]2)=[O:8])=[C:4]([S:11]([CH3:14])(=[O:13])=[O:12])[CH:3]=1Komponenten
3
Versuchsvorschrift
By reaction and treatment in the same manner as in Preparation Example 1 and using 4-bromo-2-methanesulfonylbenzoic acid (1 g) and 1-(2,4-dimethylphenyl)piperazine (684 mg), the title compound (1.3 g) was obtained.
Aufarbeitung
- customBy reaction and treatment in the same manner
- customas in Preparation Example 1
Quellen und Nachweise
- ORD-Eintrag
- ord-9153129a7300430cad265a7aff4dbb05
- Quelldatensatz
- uspto-grants-2013_01
- Patentnummer
- US08354401B2
Verknüpfte Notizen
Wird geladen…